Stockreport

This Biotech Stock Has Doubled Its Value Today—Here's Why [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF The agreement is for Monte Rosa's MRT-6160 drug and other potential treatments for immune system diseases. Shares of Monte Rosa more than doubled on the news. Share [Read more]